A clinical trial among preterm babies gives a view into corporate warfare in the high-stakes business of infant nutrition.
In 2013, a scientist at Abbott Laboratories saw study results with potentially big implications for the company’s profits and the lives of some of the world’s most fragile people: preterm infants.
The upshot, she wrote in an email: Babies fed rival M… [26807 chars]
Source: USA TODAY | Published: 2026-03-29T09:06:43Z
Credit: USA TODAY
